Qual­ity Medicines

The Sin­ga­pore-based RV Health­care PTE in­tends to im­ple­ment a project de­signed to cre­ate pro­duc­tion fa­cil­i­ties in Uzbek­istan.

Uzbekistan Today (English) - - REGIONS -

This was an­nounced dur­ing the re­cent talks be­tween the first deputy chair­man of the State In­vest­ments Com­mit­tee Sun­nat­ulla Bekenov and rep­re­sen­ta­tives of the Sin­ga­porean com­pany.

In the first stage of the project, in 2018, it is planned to open a dis­tri­bu­tion cen­ter with the es­tab­lish­ment of a trade en­ter­prise with for­eign in­vest­ments and the range of more than 40 types of medicines, in­clud­ing aux­il­iary sub­stances.

In the sec­ond phase of the project, in 2019-2020, the Sin­ga­porean part­ners in­tend to trans­fer tech­nolo­gies for the pro­duc­tion and pack­ag­ing of high-tech an­tivi­ral medicines (hep­ati­tis B, C and an­tiretro­vi­ral drugs), oral anti-can­cer drugs, in­jec­tions and bio-stim­u­la­tors. And fi­nally, in the third part, in 2021-2022, it is pro­jected to launch full-cy­cle pro­duc­tion of phar­ma­ceu­ti­cals.

It is worth not­ing that RV Health­care PTE is one of the ma­jor phar­ma­ceu­ti­cal man­u­fac­tur­ers in Asia. It has three man­u­fac­tur­ing plants in In­dia, two mills in Viet­nam and Myan­mar, and one en­ter­prise each in main­land China and Hong Kong, Cam­bo­dia, the United King­dom, Thai­land, Kaza­khstan and the Philip­pines.

Newspapers in English

Newspapers from Uzbekistan

© PressReader. All rights reserved.